Heart Failure With Preserved Ejection Fraction Expert Panel Report: Current Controversies and Implications for Clinical Trials

Kishan S. Parikh, Kavita Sharma, Mona Fiuzat, Howard K. Surks, Jyothis T. George, Narimon Honarpour, Christopher Depre, Patrice Desvigne-Nickens, Richard Nkulikiyinka, Gregory D. Lewis, Mardi Gomberg-Maitland, Christopher M. O'Connor, Norman Stockbridge, Robert M. Califf, Marvin A. Konstam, James L. Januzzi, Scott D. Solomon, Barry A. Borlaug, Sanjiv J. Shah, Margaret M. RedfieldG. Michael Felker

Research output: Contribution to journalReview article

Abstract

The number of persons with heart failure has continued to rise over the last several years. Approximately one-half of those living with heart failure have heart failure with preserved ejection fraction, but critical unsolved questions remain across the spectrum of basic, translational, clinical, and population research in heart failure with preserved ejection fraction. In this study, the authors summarize existing knowledge, persistent controversies, and gaps in evidence with regard to the understanding of heart failure with preserved ejection fraction. Our analysis is based on an expert panel discussion “Think Tank” meeting that included representatives from academia, the National Institutes of Health, the U.S. Food and Drug Administration, the Centers for Medicare & Medicaid Services, and industry.

Original languageEnglish (US)
Pages (from-to)619-632
Number of pages14
JournalJACC: Heart Failure
Volume6
Issue number8
DOIs
StatePublished - Aug 1 2018

Fingerprint

Heart Failure
Clinical Trials
Medicaid
National Institutes of Health (U.S.)
United States Food and Drug Administration
Medicare
Industry
Research
Population

Keywords

  • classification scheme
  • diagnosis
  • diastolic
  • ejection fraction
  • endpoints
  • heart failure
  • pathophysiology
  • preserved ejection fraction
  • pulmonary hypertension
  • subject eligibility
  • treatment

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Heart Failure With Preserved Ejection Fraction Expert Panel Report : Current Controversies and Implications for Clinical Trials. / Parikh, Kishan S.; Sharma, Kavita; Fiuzat, Mona; Surks, Howard K.; George, Jyothis T.; Honarpour, Narimon; Depre, Christopher; Desvigne-Nickens, Patrice; Nkulikiyinka, Richard; Lewis, Gregory D.; Gomberg-Maitland, Mardi; O'Connor, Christopher M.; Stockbridge, Norman; Califf, Robert M.; Konstam, Marvin A.; Januzzi, James L.; Solomon, Scott D.; Borlaug, Barry A.; Shah, Sanjiv J.; Redfield, Margaret M.; Felker, G. Michael.

In: JACC: Heart Failure, Vol. 6, No. 8, 01.08.2018, p. 619-632.

Research output: Contribution to journalReview article

Parikh, KS, Sharma, K, Fiuzat, M, Surks, HK, George, JT, Honarpour, N, Depre, C, Desvigne-Nickens, P, Nkulikiyinka, R, Lewis, GD, Gomberg-Maitland, M, O'Connor, CM, Stockbridge, N, Califf, RM, Konstam, MA, Januzzi, JL, Solomon, SD, Borlaug, BA, Shah, SJ, Redfield, MM & Felker, GM 2018, 'Heart Failure With Preserved Ejection Fraction Expert Panel Report: Current Controversies and Implications for Clinical Trials', JACC: Heart Failure, vol. 6, no. 8, pp. 619-632. https://doi.org/10.1016/j.jchf.2018.06.008
Parikh, Kishan S. ; Sharma, Kavita ; Fiuzat, Mona ; Surks, Howard K. ; George, Jyothis T. ; Honarpour, Narimon ; Depre, Christopher ; Desvigne-Nickens, Patrice ; Nkulikiyinka, Richard ; Lewis, Gregory D. ; Gomberg-Maitland, Mardi ; O'Connor, Christopher M. ; Stockbridge, Norman ; Califf, Robert M. ; Konstam, Marvin A. ; Januzzi, James L. ; Solomon, Scott D. ; Borlaug, Barry A. ; Shah, Sanjiv J. ; Redfield, Margaret M. ; Felker, G. Michael. / Heart Failure With Preserved Ejection Fraction Expert Panel Report : Current Controversies and Implications for Clinical Trials. In: JACC: Heart Failure. 2018 ; Vol. 6, No. 8. pp. 619-632.
@article{4ca1325c8fb0411abe9dbe2ff28b4586,
title = "Heart Failure With Preserved Ejection Fraction Expert Panel Report: Current Controversies and Implications for Clinical Trials",
abstract = "The number of persons with heart failure has continued to rise over the last several years. Approximately one-half of those living with heart failure have heart failure with preserved ejection fraction, but critical unsolved questions remain across the spectrum of basic, translational, clinical, and population research in heart failure with preserved ejection fraction. In this study, the authors summarize existing knowledge, persistent controversies, and gaps in evidence with regard to the understanding of heart failure with preserved ejection fraction. Our analysis is based on an expert panel discussion “Think Tank” meeting that included representatives from academia, the National Institutes of Health, the U.S. Food and Drug Administration, the Centers for Medicare & Medicaid Services, and industry.",
keywords = "classification scheme, diagnosis, diastolic, ejection fraction, endpoints, heart failure, pathophysiology, preserved ejection fraction, pulmonary hypertension, subject eligibility, treatment",
author = "Parikh, {Kishan S.} and Kavita Sharma and Mona Fiuzat and Surks, {Howard K.} and George, {Jyothis T.} and Narimon Honarpour and Christopher Depre and Patrice Desvigne-Nickens and Richard Nkulikiyinka and Lewis, {Gregory D.} and Mardi Gomberg-Maitland and O'Connor, {Christopher M.} and Norman Stockbridge and Califf, {Robert M.} and Konstam, {Marvin A.} and Januzzi, {James L.} and Solomon, {Scott D.} and Borlaug, {Barry A.} and Shah, {Sanjiv J.} and Redfield, {Margaret M.} and Felker, {G. Michael}",
year = "2018",
month = "8",
day = "1",
doi = "10.1016/j.jchf.2018.06.008",
language = "English (US)",
volume = "6",
pages = "619--632",
journal = "JACC: Heart Failure",
issn = "2213-1779",
publisher = "Elsevier BV",
number = "8",

}

TY - JOUR

T1 - Heart Failure With Preserved Ejection Fraction Expert Panel Report

T2 - Current Controversies and Implications for Clinical Trials

AU - Parikh, Kishan S.

AU - Sharma, Kavita

AU - Fiuzat, Mona

AU - Surks, Howard K.

AU - George, Jyothis T.

AU - Honarpour, Narimon

AU - Depre, Christopher

AU - Desvigne-Nickens, Patrice

AU - Nkulikiyinka, Richard

AU - Lewis, Gregory D.

AU - Gomberg-Maitland, Mardi

AU - O'Connor, Christopher M.

AU - Stockbridge, Norman

AU - Califf, Robert M.

AU - Konstam, Marvin A.

AU - Januzzi, James L.

AU - Solomon, Scott D.

AU - Borlaug, Barry A.

AU - Shah, Sanjiv J.

AU - Redfield, Margaret M.

AU - Felker, G. Michael

PY - 2018/8/1

Y1 - 2018/8/1

N2 - The number of persons with heart failure has continued to rise over the last several years. Approximately one-half of those living with heart failure have heart failure with preserved ejection fraction, but critical unsolved questions remain across the spectrum of basic, translational, clinical, and population research in heart failure with preserved ejection fraction. In this study, the authors summarize existing knowledge, persistent controversies, and gaps in evidence with regard to the understanding of heart failure with preserved ejection fraction. Our analysis is based on an expert panel discussion “Think Tank” meeting that included representatives from academia, the National Institutes of Health, the U.S. Food and Drug Administration, the Centers for Medicare & Medicaid Services, and industry.

AB - The number of persons with heart failure has continued to rise over the last several years. Approximately one-half of those living with heart failure have heart failure with preserved ejection fraction, but critical unsolved questions remain across the spectrum of basic, translational, clinical, and population research in heart failure with preserved ejection fraction. In this study, the authors summarize existing knowledge, persistent controversies, and gaps in evidence with regard to the understanding of heart failure with preserved ejection fraction. Our analysis is based on an expert panel discussion “Think Tank” meeting that included representatives from academia, the National Institutes of Health, the U.S. Food and Drug Administration, the Centers for Medicare & Medicaid Services, and industry.

KW - classification scheme

KW - diagnosis

KW - diastolic

KW - ejection fraction

KW - endpoints

KW - heart failure

KW - pathophysiology

KW - preserved ejection fraction

KW - pulmonary hypertension

KW - subject eligibility

KW - treatment

UR - http://www.scopus.com/inward/record.url?scp=85050069784&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85050069784&partnerID=8YFLogxK

U2 - 10.1016/j.jchf.2018.06.008

DO - 10.1016/j.jchf.2018.06.008

M3 - Review article

C2 - 30071950

AN - SCOPUS:85050069784

VL - 6

SP - 619

EP - 632

JO - JACC: Heart Failure

JF - JACC: Heart Failure

SN - 2213-1779

IS - 8

ER -